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Abstract
Identifying risk factors from longitudinal data requires statistical tools that are not restricted
to linear models, yet provide interpretable associations between different types of covariates and
a response variable. Here, we present a widely applicable and interpretable probabilistic machine
learning method for nonparametric longitudinal data analysis using additive Gaussian process regres-
sion. We demonstrate that it outperforms previous longitudinal modeling approaches and provides
useful novel features, including the ability to account for uncertainty in disease effect times as well
as heterogeneity in their effects.
Background
Biological and medical studies often collect obser-
vational longitudinal data, where repeated mea-
surements of the same individuals are made at
several time points. This is an indispensable
study design for examining disease development
and other temporal phenomena, and has been
leveraged for example in proteomics [1], metage-
nomics [2, 3], other -omics studies and even single-
cell transcriptomics [4, 5]. The measured response
variable of interest can be continuous (such as
abundance of a protein), discrete (such as num-
ber of methylated reads at a certain position), or
binary (such as patient condition). Often also a
number of explanatory variables – or covariates –
are measured for each subject and measurement
time point. These can be categorical variables
(such as sex, location or whether the subject is di-
agnosed with a disease or not) or continuous (such
as age, time from disease initiation or blood pres-
sure) and inferring which covariates affect the re-
sponse variable, or are potential risk factors, is a
medically motivated question. A large body of lit-
erature has focused on statistical analysis of lon-
gitudinal data [6], for the purposes of temporal
trend analysis, predictive modeling or studying co-
variate effects. Observations of one individual are
intercorrelated, and specialized statistical tech-
niques are therefore required to draw sensible con-
clusions. Generalized linear mixed (GLM) models
[7], which contain both fixed and random effects,
have become the standard workhorse for longitudi-
nal data analysis due to their general applicability,
ease of use, interpretability and software support.
The R package lme4 [8] has gained high popular-
ity and become a default choice for fitting GLM
models. These models, however, require specify-
ing a parametric (linear) form for the covariate
effects, and provide biased inferences when their
true effects are nonlinear. Moreover, GLM mod-
els cannot capture nonstationary effects that can
occur rapidly e.g. near the disease initiation time.
See Supplementary material for more background
information and related research.
Results and discussion
In this work we propose a Bayesian nonparamet-
ric method, lgpr, for modeling longitudinal data
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using additive Gaussian processes (GPs) [9]. It
is designed for accurate and interpretable learn-
ing of possibly nonlinear or nonstationary effects
of individual covariates or their interactions. We
demonstrate that our method significantly im-
proves previous longitudinal analysis methods and
provides novel features to the longitudinal mod-
eling toolkit: lgpr supports non-Gaussian obser-
vation models, includes kernels for interpretable
modeling of various types of covariate effects,
unique features that can identify heterogeneous
biomarkers that are detectable only in a subset of
patients, and a possibility to model uncertainty in
disease effect times. Furthermore, lgpr can com-
pute covariate relevances for different types of co-
variates, and perform accurate covariate selection.
We have implemented lgpr as an R package [10]
that can be used as a plug-in replacement for lme4.
The new tool is summarized in Figure 1a.
In our approach, we use GPs to model the
longitudinal response y in a Bayesian manner by
defining a prior directly for the underlying un-
known signal f , which is linked to y through a
likelihood function, which is motivated by the sta-
tistical observation model. Properties of a GP
are defined by its kernel function k(x,x′), which
encodes the covariance of function values at dif-
ferent input points. Additive GPs assume that
the signal (or equivalently the kernel) is addi-
tive, f = f (1)(x) + . . . + f (J)(x), and lgpr specif-
ically assumes that each f (j) depends only on
a single covariate or a pair of covariates (Fig-
ure 1b-c). For example, for a model with age
and sex as covariates, lgpr can model the signal
as f = f (1)(age) + f (2)(sex, age), where the first
component represents a shared age effect and the
second represents sex-specific deviation from it.
This additive model structure allows one to define
appropriate kernels for different covariates (dis-
crete, continuous or interaction), and to retrieve
interpretable covariate effects after model fitting.
For components like f (2), we use a zero-sum ker-
nel (Supplementary material: Figure S1) which
is similar to the kernel used in [11] and allows
GP modeling that separates shared and category-
specific effects.
Parameters of an lgpr model include parame-
ters of the observation model and the kernel (hy-
per)parameters, among others, and they are as-
signed robust priors that regularize model fitting
(Supplementary material: Figure S2). Bayesian
model inference is carried out using the dynamic
Hamiltonian Monte Carlo sampler [12, 13], as
implemented in the high-performance statistical
computation framework Stan [14]. We develop a
rigorous and interpretable probabilistic covariate
selection method which is based on fitting only
one model with all covariates and estimating the
proportion of variance explained by each signal
component and noise. A detailed description of
the modeling and inference methodology is given
in Supplementary material. Using simulated data,
we show that lgpr results in better covariate selec-
tion accuracy than linear mixed modeling with sig-
nificance testing (Figure 2a, Supplementary ma-
terial: Figure S3a) and an earlier Gaussian pro-
cess regression method LonGP [15] (Supplemen-
tary material: Figure S3b).
Due to computational convenience, GP regres-
sion usually assumes a continuous Gaussian obser-
vation model, which is not statistically appropri-
ate when modeling discrete count data as com-
monly produced in -omics studies. A common ap-
proach is to use the Gaussian observation model
after first applying a variance-stabilizing trans-
form, such as log-transform, to the response vari-
able, but this is not statistically justified and can
lead to biased inferences [16]. As a notable exten-
sion to existing literature, our package implements
additive GP modeling and covariate selection also
in the case of a non-Gaussian observation model
(Supplementary material). We have implemented
exact inference under the Poisson, Bernoulli, bi-
nomial and negative binomial (NB) observation
model, and extending the lgpr tool with other ob-
servation models is straightforward. We use simu-
lated longitudinal count data to show that using a
negative binomial observation model gives better
covariate selection accuracy than Gaussian obser-
vation model with or without log-transforming the
counts (Figure 2b).
Longitudinal studies often comprise a case and
control group, and it is common that a clinically
determined time of disease initiation for each case
individual is marked in the data. In order to reveal
phenomena related to disease progression or to
identify biomarkers, statistical modeling can uti-
lize the disease-related age, i.e. time from disease
initiation or onset, as one covariate that can ex-
plain changes in the response variable. Disease ef-
2
fects can be rapid when compared to other effects
and expected to occur near the time of disease
initiation, and which is why a nonstationary GP
kernel is justified for the disease-related age. This
approach was used in [15]. We propose a new vari-
ance masking kernel for more interpretable model-
ing of non-stationary disease effects (Supplemen-
tary material: Figure S4). The proposed approach
separates the effect caused by the disease initiation
from a possible baseline difference between cases
and controls.
An inherent problem that can confound the
analysis of disease effects, is that the disease initi-
ation (or onset) time is difficult to determine ex-
actly. For example in Type 1 Diabetes (T1D), the
presence of islet cell autoantibodies in the blood
is the earliest known marker of disease initiation
[17], but they can only be measured when the sub-
ject visits a doctor. In general, the detected dis-
ease initiation time can differ from the true ini-
tiation time, and the magnitude of this difference
can vary across individuals and response variables.
Our tool can account for uncertainty in the dis-
ease effect time, and provides an option for the
user to set a prior for the effect times globally or
relative to the clinically determined onset or initi-
ation time. This important feature could even re-
veal previously unknown biomarkers, which, at a
younger age than known markers, predict the risk
of developing a disease. Using simulated data, we
show that modeling the effect time uncertainty im-
proves the accuracy of detecting the disease effect
(Figure 2c, Supplementary material: Figures S5-
S6).
Another challenge in biomedical studies is that
many diseases, such as T1D, are heterogeneous
[18], and disease-specific biomarkers are likely to
be detectable in only a subset of the diagnosed in-
dividuals. Our package also includes unique fea-
tures for modeling heterogeneous disease effects.
The disease effect size is allowed to vary between
individuals, yet the statistical power from all di-
agnosed subjects is utilized (Supplementary ma-
terial: Figure S4). Using simulated data, we show
that if the real effect is not present for all diag-
nosed individuals, the heterogeneous modeling ap-
proach improves covariate selection accuracy (Fig-
ure 2d, Supplementary material: Figures S7-S8).
Furthermore, the inference results provide infor-
mation about which case subjects are affected by
the disease (Figure 2e,g,l, Supplementary mate-
rial: Figure S7).
We used lgpr to analyze a longitudinal data
set from a recent T1D study [1], where the lon-
gitudinal profile of plasma proteins was measured
from 11 cases and 10 controls at nine time points
that span the initiation of the disease pathogene-
sis. We performed the analysis for 1538 proteins
separately, using both the homogeneous and het-
erogeneous disease effect modeling approach. In
total, the homogeneous model finds 38 and the
heterogeneous model finds 66 proteins associated
with the disease-related age covariate, with in-
tersection of 20 proteins. Covariate selection re-
sults for all proteins are included in Supplemen-
tary Tables S1-S2. Figure 2f shows the normal-
ized measurements for Protein Q8WA1 (O-linked-
mannose beta-1,2-N-acetylglucosaminyltransferase
1 ) and Figures 2h-i show the inferred covariate ef-
fects using two different disease effect modeling
approaches. The new heterogeneous modeling ap-
proach is seen to detect a stronger average dis-
ease effect, because it allows the effect sizes to
vary between individuals. Moreover, the poste-
rior distributions of individual-specific disease ef-
fect magnitude parameters (Figure 2l), reveal four
individuals (id = 15, 16, 17, 21) (Figure 2g), that
experience a strong disease effect near the sero-
conversion time.
Conclusions
The lgpr tool provides several important novel fea-
tures for modeling longitudinal data, and offers a
good balance between flexibility and interpretabil-
ity. We have shown that the interpretable kernels,
heterogeneous disease modeling, uncertainty mod-
eling of effect times, and covariate selection strat-
egy of lgpr significantly improve previous longi-
tudinal modeling methods. The tool has an in-
tuitive syntax, and thus provides an easy tran-
sition from the standard tools to Bayesian non-
parametric longitudinal regression. It is generally
applicable as the data can involve irregular sam-
pling intervals or different number of measurement
points over individuals and enjoys state-of-the art
posterior sampling efficiency and diagnostics [19]
offered by Stan. Moreover, many types of response
variables that are common in postgenomic stud-
ies (continuous, discrete, binary, proportion) can
3
be modeled with the proper observation model.
The user can choose from the numerous presented
modeling options and set various parameter priors
(which have widely applicable defaults). Overall,
lgpr has potential to become a standard tool for
statistical analysis of longitudinal data.
Methods
See Supplementary material for full description of the
used methodology.
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Figure 1 | Overview of additive Gaussian process modeling of longitudinal data using lgpr. a) A
typical workflow with lgpr. 1. User gives the data and model formula as input, along with possible additional
modeling options such as non-default parameter priors or a discrete observation model. 2. The model is fitted by
sampling the posterior distribution of the model parameters. 3. Relevances of different covariates and interaction
terms are computed and given as output. Covariate selection can be performed directly from the posterior
distribution of the full model with all covariates included. The learned signal components can be visualized to
study the magnitude and temporal aspects of different covariate effects. If a heterogeneous disease model was
specified, the results inform about the heterogeneity of the possibly discovered disease effect. b) Illustration of
different types of covariate effects that can be modeled using lgpr. The components f (j), j = 1, . . . , 5 are draws
from Gaussian process priors. This artificial data comprises 8 individuals (4 male, 4 female), and 2 individuals
of each sex are cases. The shown age-dependent components are a shared age effect f (1), a sex-specific deviation
f (2) from the shared age effect, a disease-related age (diseaseAge) effect f (3), and a subject-specific deviation
f (5) from the shared age effect. For each of the diseased individuals, the disease initiation occurs at a slightly
different age, between 20 and 40 months. The component f (4) is a function of blood pressure only, but is plotted
against age for consistency as the simulated blood pressure variable has a temporal trend. c) The cumulative
effect f =
∑
j f
(j) is a sum of the low-dimensional components. Our method learns each f (j) from data, without
having to specify a parametric form.
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Figure 2 | Novel features of lgpr improve covariate selection accuracy and provide useful infor-
mation about disease effects. a)-d)Receiver operating charasteristic (ROC) curves for the task of classifying
covariates as relevant or irrelevant in simulated data experiments (described in Supplementary material). The
ROC curves are computed over 100–300 simulated data sets each. a) Comparison between lgpr (our method)
and linear mixed modeling using the lme4 and lmerTest packages, when the true covariate effects are nonlinear.
b) Using a discrete observation model improves covariate selection accuracy for negative binomially distributed
count data. c) Modeling the uncertainty in disease effect time improves covariate selection accuracy, when the
true effect has happened earlier than the clinically determined disease initiation. Here the ROC curve is for the
task of classifying just the disease component as relevant or irrelevant (more details in Supplementary material,
Figures S5-S6). d) Heterogeneous disease effect modeling improves covariate selection accuracy compared to the
homogeneous approach, when the true disease effect is heterogeneous (4 out of 8 diseased individuals experience
the effect). e) The individuals that experience the effect (id = 1–4) can be identified based on the posterior
distribution of the βid parameters, which are hyperparameters of our heterogeneous disease kernel, describing
individual-specific disease effect magnitude. The boxplot describes the distribution of the posterior medians of
the βid parameters, over 100 simulated data sets (more details in Supplementary material, Figures S7-S8). The
box is the interquantile range (IQR) between the 25th and 75th percentiles, vertical line inside the box is the
50th percentile, and the whiskers extend a distance of at most 1.5 · IQR from the box boundary. f) - l) Results
of analysing one example protein from a longitudinal proteomics data set. f) The normalized measurements
for protein Q8WZA1, highlighted based on group (case or control). The lines connect an individual. g) Same
data where four case individuals (id=15, 16, 17, 21) are highlighted, based on being determined as affected by
the disease in heterogeneous modeling. h) Learned additive function components, as well as their sum f (using
posterior mean parameters), for Q8WZA1 analyzed using the homogeneous and i) heterogeneous model. For
clarity, standard deviations are not show for f (1) and fsum. j) Average relevances and k) selection probabilities
for each component of the homogeneous and heterogeneous model. l) Kernel density estimates for the posterior
distributions of the individual-specific disease effect magnitude parameters of the heterogeneous model.
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1 Model
1.1 Gaussian processes
A Gaussian process (GP) is a collection of random variables, any finite number of which has a multivari-
ate normal distribution [1]. A function f : X → R has a GP prior f(x) ∼ GP (m(x), k(x,x′)) with mean
function m(x) and kernel function k(x,x′), if for any finite number of inputs {xp ∈ X}Pp=1, the vector
of function values f = [f(x1), . . . , f(xP )]> has a multivariate normal prior f ∼ N (m,K) with mean
vector m = [m(x1), . . . ,m(xP )]> and covariance matrix K ∈ XP×P with entries {K}ij = k(xi,xj).
In this study, we only use a zero mean function m(x) = 0. The kernel function must be positive semi-
definite and it encodes information about the covariance of function values at different points. Choosing
a suitable kernel function therefore is an essential part of GP modeling.
1.2 Additive GPs for longitudinal data
We denote a longitudinal data set with N data points, D covariates, and one response variable, by a
tuple (X,y), whereX is an N ×D covariate matrix and y ∈ RN is a vector of measured responses. We
refer to a row ofX by x ∈ X , where X = ×Dd=1Xd and Xd is the set of possible values for covariate d. In
general, Xd can be a discrete set such as {“Male”, “Female”} or a connected set such as R. We assume
that a time variable and a subject identifier variable are included in the set of available covariates,
meaning that D ≥ 2. It is possible that there is a different number of measurements for different
subjects, and that the measurement times have irregular intervals. Since our focus is on biomedical
data, we will from now on refer to subjects as individuals and measurement time as age.
In our modeling framework, we assume that there is an underlying unobserved signal f : X → R
that is a function of the covariates. This signal is linked to the measured responses through a likelihood
function, which is based on a statistical observation model. The process f is assumed to consist of J low-
dimensional additive components, so that f(x) = f (1)(x)+ . . .+f (J)(x), where each f (j), j = 1, . . . , J is
a function of only one or two covariates. This is a sensible assumption in many real-world applications
and apt to learn long-range structures in the data [2]. Furthermore, this decomposition into additive
components allows us to obtain interpretable covariate effects after fitting the model. In our approach,
each component has a GP prior f (j)(x) ∼ GP(0, α2jkj(x,x′)), and because the components are a priori
independent, we can write
f(x) ∼ GP (0, k(x,x′)) , (1)
where k(x,x′) =
∑J
j=1 α
2
jkj(x,x
′). The parameter α2j is called the marginal variance of component f
(j)
and it determines how largely the component varies. The base kernel functions kj(x,x′) are constructed
based on what covariates are included in the model and what modeling options are selected.
1.2.1 Continuous covariates
Shared effects of continuous covariates are modeled using the kernel
kcont(x,x
′ | `cont) = keq(xcont, x′cont | `cont), (2)
where
keq(x, x
′ | `) = exp
(
−(x− x
′)2
2`2
)
(3)
is the exponentiated quadratic kernel. Here, xcont refers to a generic continuous covariate, each of which
have their own lengthscale parameter `cont, which determines how rapidly the component can vary. For
example, a shared age effect kernel is kage(x,x′ | `age) = keq(xage, x′age | `age).
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1.2.2 A zero-sum kernel for categorical covariates
We assume that for any given individual, the value of a categorical covariate does not differ between
time points. Effects of categorical covariates (such as id or sex) can be modeled either as time-dependent
deviations from a shared age effect or as group-specific constant offsets. If xcat is a categorical covariate
with M ≥ 2 categories, and whose effect is modeled in the time-dependent manner, the corresponding
kernel function is
kcat×age(x,x′ | `cat) = kzerosum(xcat, x′cat) · keq(xage, x′age | `cat), (4)
where
kzerosum(r, r
′) =
{
1 if r = r′
− 1M−1 otherwise
(5)
is the zero-sum kernel. This is similar to the Gaussian process ANOVA approach in [3]. It has a property
that if f : R×{1, . . . ,M} → R is modeled as a GP f ∼ GP(0, kcat×age), the sum
∑M
r=1 f(t, r) is always
zero for any t (see proof in Appendix A). This means that f represents a time-dependent category-
specific deviation from the shared age effect (see Figure S1 for illustration). In other words, the fact
that the average across categories equals exactly zero for any t greatly helps model interpretation as
this property guarantees that categorical covariates cannot bias the shared effects. Note that again xcat
refers to a generic categorical covariate, and each such covariate has its own lengthscale parameter `cat.
This kernel structure can be used for modeling category-specific deviations from the shared effects of
other continuous covariates as well, but it is left out of the focus of this study. In the time-independent
case, the covariate effect corresponds to a constant offset for each category, and the corresponding kernel
function is
koffset(x,x
′) = kzerosum(xcat, x′cat). (6)
This is a special case of the time-dependent case when `cat → ∞, and can be used for example for
modeling batch offsets that do not depend on time.
1.2.3 Nonstationary disease effect modeling
Disease effects are modeled using a nonstationary kernel for the disease-related age xdisAge, i.e. time
from disease initiation or onset. This is motivated by the assumption that most changes in that function
component occur near the event of disease occurrence, i.e. near xdisAge = 0. Note that for the control
subjects, xdisAge is not observed at all. The disease kernel functions defined below actually will return
0 if either of the inputs corresponds to a healthy individual, but for cleaner notation, we write them
assuming that there are no healthy individuals. Nonstationarity is achieved by first mapping the inputs
through a monotonic nonlinear input warping function ω : R→]− 1, 1[, defined as
ω(x | a) = 2 ·
(
1
1 + e−ax
− 1
2
)
, (7)
where the parameter a controls the warping steepness, and then using the exponentiated quadratic
kernel for the warped inputs. This approach was used in [4] where the kernel function was
kns(x,x
′ | a, `disAge) = keq(ω(xdisAge | a), ω(x′disAge | a) | `disAge). (8)
Whereas the kernel in Eq. 8 can model a nonstationary trend that is only present for the diseased
individuals, its drawback is that it will also capture effects that are merely a different base level between
the diseased and healthy individuals. For better interpretability, these effects should be explained by
the binary covariate that describes membership of either of these two groups, instead of the continuous
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disease-related age covariate. To account for this, we design a new kernel for the disease-related age
component, defined as
kdisAge(x,x
′ | a, `disAge) = fvm(xdisAge | a) · fvm(x′disAge | a) · kns(x,x′ | a, `disAge), (9)
where fvm(x | a) : R→]0, 1[ is a variance mask function that forces the disease component to have zero
variance, i.e. the same value for both groups, when x→ −∞. We choose to use
fvm(x | a) = 1
1 + e−a(x−r)
, (10)
which means that the allowed amount of variance between these groups rises sigmoidally from 0 to the
level determined by the marginal variance parameter, so that the midpoint is at r = 1a log
(
h
1−h
)
and
ω(r | a) = 2h − 1. The parameter h therefore determines a connection between the regions where the
disease component is allowed to vary between the two groups and where it is allowed to vary over time.
In our experiments, we use the value h = 0.025. This means, that 95% of the variation in ω occurs
on the interval [−r, r]. The disease kernels in Eq. 8 and Eq. 9 as well as functions drawn from the
corresponding GP priors are demonstrated in Figure S4.
1.3 Modeling a heterogeneous disease effect
In Eq. 9, we presented a kernel for modeling a disease effect that is equally strong for all diagnosed
individuals. In order to allow effects whose strength is heterogeneous over the diagnosed individuals
or is completely absent from some case individuals, we define additional parameters β = [β1, . . . , βQ],
where Q is the number of diagnosed individuals and each βi ∈ [0, 1]. We design a new kernel
kheter(x,x
′ | a, `disAge,β) =
√
βqβq′ · kdisAge(x,x′ | a, `disAge), (11)
where the case indices q = I(xid) and q′ = I(x′id) are determined by a bijection I : XcaseID → {1, . . . , Q},
where XcaseID is the set of subject IDs for the case individuals. In other words, we want to allow effects
of different magnitude for different case subjects, yet using all available statistical power by modeling
the effects of diseased individuals as correlated. In our implementation, the prior for the unknown
parameters β is set to βi ∼ Beta(b1, b2), where the shape parameters b1 and b2 can be defined by the
user. By default, we set b1 = b2 = 0.2, in which case most of the prior mass is near the extremes 0
and 1 (Figure S2c). The posterior distributions of βi can then be used to make inferences about which
case individuals are affected by the disease. The kernel in Eq. 11 is illustrated in Figure 4, along with
functions drawn from the corresponding GP prior.
1.4 Modeling uncertainty in the disease effect time
The presented disease effect modeling approach relies on observing the disease-related age for each case
individual. It is defined as xdisAge = xage−t′q for diseased individual q, where t′q is the disease effect time
for that subject. In [4], this effect time was defined as the age of subject q at the clinically determined
disease initiation time, but in general the effect time can differ from it. Our implementation allows
Bayesian inference also for the effect times, and can therefore capture nonstationary disease effects that
for some or all individuals occur at a different time point than the clinically determined initiation. The
user can set the prior either directly for the effect time t′, or for the difference between the effect time
and observed initiation time, ∆t = tobs − t′. The first option is suitable if the disease is known to
commence at certain age for all individuals. The latter option is useful in a more realistic setting where
such information is not available, and one would like to set the prior so that the clinically determined
initiation times tobs have a high probability.
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1.5 Observation models
We have implemented five different likelihood models that relate the observed data and the underlying
signal f . Below, we use notation fi = f(xi), y¯ = 1N
∑N
i=1 yi, logistic(x) =
1
1+exp(−x) and logit(x) =
log
(
x
1−x
)
.
• The Gaussian observation model for continuous data is yi = fi + εi, where εi ∼ N
(
0, σ2e
)
. The
parameter σ2e which quantifies noise variance.
• The Bernoulli observation model for binary data is yi ∼ Bernoulli(pi), where pi = logistic(Cˆ + fi)
is the success probability. By default, we set Cˆ = logit(y¯).
• In the binomial observation model for count data, the vector containing the numbers of trials
η = [ηi, . . . , ηN ]
> is supplied as data, along with y, which now is the vector of numbers of
observed successes. The model is yi ∼ Binomial(pi, ηi), where pi = logistic(Cˆ + fi) is the success
probability. By default, we set Cˆ = logit( 1N
∑N
i=1 yi/ηi).
• The Poisson observation model for count data is yi ∼ Poisson
(
exp(Cˆ + fi)
)
. By default, we set
Cˆ = log(y¯).
• The negative binomial (NB) observation model for count data is yi ∼ NB
(
exp(Cˆ + fi), φ
)
, where
φ is an inverse overdispersion parameter. By default, we set Cˆ = log(y¯). Here we use the
parametrization for which
X ∼ NegBinomial(x, φ) ⇐⇒ E[X] = x, Var[X] = x+ x
2
φ
. (12)
Our software package, lgpr, can be easily extended with additional observation models depending on
users’ needs.
2 Inference
2.1 Posterior inference
Our covariate selection procedure relies on first building a full model which includes all available co-
variates, and then studying the posterior distribution of the unknowns of this model, mostly focusing
on that of the function components. We collect all marginal variances, lengthscales and other possi-
ble kernel hyperparameters into a vector θkernel. Similarly, we denote the parameters related to the
observation model by θobs and other parameters such as those related to input uncertainty by θother.
The collection of all unknown model parameters is then θ = {θkernel,θobs,θother}. We use the dynamic
Hamiltonian Monte Carlo sampler [5] with multinomial sampling of dynamic length trajectories [6], as
implemented in Stan [7], to draw S samples from the posterior distribution of θ.
The remaining unknowns of the model are the values of the function components, for which we use
the notation f (j) = [f (j)(x1), . . . , f (j)(xN )]>, where xi is the ith row of X, and f =
∑J
j=1 f
(j). Under
the Gaussian observation model and fixed parameters θ, the posterior distributions of f (1), . . . ,f (J)
and f can be derived analytically. For readability, we for now assume that θ are fixed and drop the
dependency on θkernel off the notation of kernel matrices. The kernel matrix corresponding to component
j is denoted by K(j), and its entries are {K(j)}ik = α2jkj(xi,xk | θkernel), and the full additive kernel
matrix is denoted byK =
∑J
j=1K
(j). Under the Gaussian observation model and the prior of f defined
by Eq. 1, the joint density of y and f is also Gaussian[
f
y
]
∼ N
([
0
f
]
,
[
K K
K K + σ2eI
])
. (13)
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Using the Gaussian conditioning formula, we get the posterior p (f | y) = N (f | µ,Σ), where{
µ = K(K + σ2eI)
−1y
Σ = K −K(K + σ2eI)−1K
. (14)
Similarly, the posterior distribution of component j becomes p
(
f (j) | y) = N (f (j) | µ(j),Σ(j)), where{
µ(j) = K(j)(K + σ2eI)
−1y
Σ(j) = K(j) −K(j)(K + σ2eI)−1K(j)
. (15)
Furthermore, the posterior distribution of f∗ = [f(x∗1), . . . , f(x∗P )]
>, where x∗p, p = 1, . . . , P are unob-
served data points is p(f∗ | y) = N (µ∗,Σ∗) with{
µ∗ = K∗(K + σ2eI)−1y
Σ∗ = K∗∗ −K∗(K + σ2eI)−1K>∗
, (16)
whereK∗ is the P ×N kernel matrix between test and data points, andK∗∗ is the P ×P kernel matrix
between test points. We then obtain the posterior predictive distribution
p(y∗ | y) = N (µ∗,Σ∗ + σ2I) . (17)
Also the component posteriors p
(
f
(j)
∗ | y
)
are multivariate Gaussian with mean and covariance{
µ
(j)
∗ = K
(j)
∗ (K + σ2eI)−1y
Σ
(j)
∗ = K
(j)
∗∗ −K∗(K + σ2eI)−1K(j)
>
∗
, (18)
where the kernel matrices with superscript j are computed using only the jth kernel function. Eqs. 17
and 18 are needed in this study only for visualization purposes. For the non-Gaussian observation
models, the posterior distributions of f or f (j) given fixed hyperparameters are not available analytically.
In this case we therefore sample the posterior of each f (j) simultaneously with θ. Because these
function values will have strong posterior correlations, we reparametrize the problem using Cholesky
decompositions of the kernel matrices K(j) = L(j)L(j)> , so that we only need to sample auxiliary
variables ξ(j), which are defined by f (j) = L(j)ξ(j) and have less posterior correlations.
2.2 Covariate selection
In our covariate selection method, we first determine the proportion of variance explained by noise and
each function component. After posterior sampling, we have S parameter samples
{
θ(s)
}S
s=1
and in
the case of a non-Gaussian observation model, also samples
{
f (j,s)
}S
s=1
of each function component
j = 1, . . . , J . For each sample s, our model gives predictions y∗s =
[
y∗1,s, . . . , y∗N,s
]
. These are defined
differently depending on the observation model.
• When using the Gaussian observation model, these are defined as y∗s = µs, i.e. the analytically
computed mean prediction in Eq. 14 with parameter values set to θ(s).
• With Poisson or NB model we use y∗s = exp
(
Cˆ +
∑J
j=1 f
(j,s)
)
.
• With Bernoulli model y∗s = logistic
(
Cˆ +
∑J
j=1 f
(j,s)
)
.
• With Binomial model, y∗s = η  logistic
(
Cˆ +
∑J
j=1 f
(j,s)
)
∗.
∗ = elementwise multiplication
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The constant Cˆ is defined for each model as in Section 1.5. To determine how much of the data is
explained by noise, we compute
p
(s)
noise =
RSSs
ESSs +RSSs
∈ [0, 1] (19)
using the residual sum of squares RSSs =
∑N
i=1 = (y
∗
i,s − yi)2 and explained sum of squares ESSs =∑N
i=1 = (y
∗
i,s−y¯∗s)2, where y¯∗s = 1N
∑N
i=1 y
∗
i,s. Note that in ordinary linear regression, one would typically
use y¯ = 1N
∑N
i=1 yi in the place of y¯
∗
s so that ESS+RSS = TSS =
∑N
i=1(yi− y¯)2. However, for general
nonlinear regression, this decomposition does not hold. Furthermore, the related classical R2 statistic
is problematic for Bayesian models [8]. We argue that for our model it is more reasonable to define
ESS based on the variation of the predictions instead of based on the squared difference of predictions
and the mean of observed data. With our definition, p(s)noise will be one if the model gives constant
predictions and zero if predictions match data exactly.
After computing p(s)noise, we further divide the proportion of variance that is associated with the actual
signal, p(s)signal = 1 − p(s)noise, for each model component. For cleaner notation, we define the variation of
a vector v = [v1, . . . , vL] as a sum of squared differences from the mean, i.e. SS(v) =
∑L
l=1 (vl − v¯l)2.
The relevance of component j, in sample s, is defined as
rel(s)j =
(
1− p(s)noise
) SS(s)j∑J
j′=1 SS
(s)
j′
(20)
where SS(s)j = SS
(
µ(j,s)
)
with Gaussian observation model and SS(s)j = SS
(
f (j,s)
)
otherwise. Above
we used µ(j,s) to denote the mean vector in Eq. 15, corresponding to sample s. The final component
and noise relevances are then obtained as averages
relj =
1
S
S∑
s=1
rel(s)j and pnoise =
1
S
S∑
s=1
pnoise(s) (21)
over the S MCMC samples. Our definition of component relevances has the beneficial property that we
can compute the proportion of variance explained by a subset of components J ⊆ {1, . . . , J} simply as
relJ =
∑
j∈J
relj . (22)
Furthermore, it follows that
1. rel{1,...,J} = 1− pnoise = psignal
2. relA < relB if A,B ⊆ {1, . . . , J} and A ⊂ B
3. rel∅ = 0.
Property 2 states that adding more components will always increase the explained variance. Therefore,
our covariate selection method is based on selecting the minimal subset of components Jsel that together
with noise explain at least T% of variance. Formally,
Jsel = arg minJ |J | s.t. relJ + pnoise ≥
T
100
, (23)
and T = 95 by default. The user change the desired threshold T according their preferences, taking
into account the total number of model components and amount of noise in the data. In the sense
of selecting a minimal subset of covariates based on inference of a full model with all covariates, our
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method is similar to the projection predictive model selection method [9], which has been shown to
perform well in predictive covariate selection for generalized linear models [10]. However, in our case
finding the minimal subset is trivial and does not require additional sampling or parameter fitting. Due
to the additivity property in Eq. 22, it reduces to just sorting the list of relevances {rel1, . . . , relJ}.
Furthermore, computing relevances based on only the full model with all covariates included provides a
safeguard against overfitting during a sequential subset search. This is exceptionally important because
our model usually contains components that have different complexities. For example, an individual-
specific age component has the ability to model more complex data than a group-specific age component.
The selected covariates and interactions are defined directly as the variables that the selected com-
ponents are functions of.
2.3 Probabilistic covariate selection
The above selection strategy is to tackle the task of classifying a component/covariate as relevant or
irrelevant. To provide a more informative and interpretable results, we present here a method for
computing a selection probability for each component. The method is based on defining the relevance
of component j in sample s as in Equation 20 and repeating the selection procedure in Eq. 23 for each
sample s = 1, . . . , S separately. The selection probability pj(T ) of component j is then the proportion
of times it was selected in the total S selection tasks. This method still requires setting the threshold
T , but is less sensitive with respect to it than the non-probabilistic selection. In order to avoid having
to set a fixed threshold T at all, one can instead compute the selection probabilities as
pj =
∫ 1
0
pj(T )w(T )dT, (24)
where w(T ) is a weight distribution that satisfies
∫ 1
0 w(T )dT = 1. Our package provides a routine for
this using simple numerical quadrature.
2.4 Prior specification
Our software implementation allows the user to set various different priors for the sampled hyperpa-
rameters. To allow general prior specifications for the lengthscales, all continuous covariates are scaled
to have unit variance and zero mean. An exception to this is the disease-related age, because its
lengthscale prior needs to be set only for the warped inputs that lie on the interval [−1, 1]. When
using the Gaussian observation model, also the response variable is standardized this way for easier
specification of priors for the marginal variance and noise variance parameters. Unless otherwise stated
in the experiments, we use a Student-t+ν prior with ν = 20 for all marginal standard deviations, and
a Log-Normal(0, 1) prior for the lengthscale parameters. If using the Gaussian observation model, we
use an Inverse-Gamma(2, 1) prior for the noise variance parameter. For the input warping steepness,
our default prior is Inverse-Gamma(14, 5), which has most of its probability mass between 0.2 and 0.8.
These are set based on assuming that the disease-related age is expressed in months. At extreme case
a = 0.2, the input warping (Eq. 7) allows changes in the disease component virtually only 24 months
before and after the disease effect time point. At the other end, the value a = 0.8 allows the disease
component to vary virtually only 6 months before and after the effect time point. The default priors
are visualized in Figure S2.
3 Details of experiments with simulated data
We use simulated data to create various scenarios for testing the presented modeling and covariate
selection framework. In each experiment, we generate artificial longitudinal data sets that comprise
several individuals and multiple measurements for each individual. The number of measurement points
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P is the same for each individual. In addition to having subject id and age as covariates, we also generate
different types of continuous and categorical covariates. For each individual the value of any categorical
group covariate is constant over all time points and is drawn from the binomial distribution with p = 0.5.
Continuous covariates other than age and disease-related age are generated so that for each subject i,
the value of covariate x at the kth measurement point is xik = sin(ai · sk + bi) + ci, where s1, . . . , sP are
equispaced on the interval [0, 2pi] and the values ai, bi, ci are drawn independently for each subject and
covariate so that ai ∼ Uniform
[
pi
8 ,
pi
4
]
, bi ∼ Uniform [pi, 2pi] and ci ∼ Uniform [−0.5, 0.5]. In order to test
how accurately the relevant covariates can be identified, we simulate the response variable so that some
covariates are relevant and some are not. To be specific, we first generate additive components fj from
GP priors, as illustrated in Main Figure 1. The components are scaled so that the effect size (variance)
is one for relevant components and zero for the irrelevant ones. Effects of categorical covariates are
always included as deviations from a shared age effect in both simulation and inference. The response
variable measurements y are generated from f by adding Gaussian distributed noise, except for in
our experiment with count data (Section 3.5). In the experiments, we run four independent dynamic
HMC chains for 2000 iterations, and the first half of each chain is considered as warmup. In each
experiment we generate several random replications of the simulation and measure performance in
classifying covariates into relevant or irrelevant using the area under curve (AUC) measure for receiver
operating characteristic (ROC) curves. Higher AUC value indicates better performance. The computed
covariate relevances (Eq. 21) are used as a score in the ROC analysis, which is performed using the
pROC package [11].
3.1 Comparison with linear mixed effect modeling
In the first experiment we confirm that the linear mixed modeling approach cannot capture the covariate
relevances whereas our GP modeling approach can, when the covariate effects are nonlinear. In order to
demonstrate that our method also scales to larger data sets, we repeat the comparison using N = 100,
300 and 600 as the data set size, generating 100 data sets in each case. We set the signal-to-noise ratio
to only 0.2 so that a lot of data is required to reveal the relevant covariates. The 100, 300 and 600 data
points are generated so that the number of individuals is 20, 30, and 30, and the measurement times
are at {12 ·m}5m=1, {6 · i}10m=1 and {3 ·m}20m=1 months, respectively. We generate data so that it contains
an individual-specific and a shared age effect, as well as three categorical covariates z1, z2, z3 out of
which only z1 is relevant. A lengthscale of 24 months is used to draw the shared age component, and a
lengthscale of 12 months for the individual and category-specific age-dependent deviation components.
In linear mixed effect modeling, we use the lmer model fitting command of the the lme4 package [12]
with formula y ∼ 1 + age + (age|id) + z1 + z2 + z3. Significance of the covariates zj , j = 1, 2, 3
is then estimated with the lmerTest package [13] by computing the p-value of an F-test for single-term
deletions with the default Satterthwaite approximation for denominator degrees of freedom. Because it
is not straightforward to compute covariate significances for the id and age covariates in linear mixed
effect modeling, we restrict the covariate selection problem to only these three categorical covariates. In
GP modeling, the covariate relevances are inferred by sampling the full model with an individual-specific
and a shared age component, as well as one category-specific deviation component corresponding to
each categorical covariate. We generate 100 data sets independently, and compute ROC curves using
the p-values as a score in linear modeling. The resulting ROC curves and AUC scores are shown in
Figure S3a.
3.2 Comparison with LonGP
We also compare our method with the additive Gaussian process model selection method LonGP [4],
which models non-stationary disease effects using the kernel in Eq. 8. Here we set up a more difficult
covariate selection problem with more covariates of different types. We generate individual-specific,
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shared, and disease-related age effects, as well as four other categorical covariates that interact with
age as category-specific age-dependent deviations from the shared age effect, and four more continuous
covariates. We generate data with 16 individuals, measured at time points 12, 24, 36, 48, 60 and
72 months, resulting in N = 96 data points. Furthermore, we add Gaussian jitter with σt = 1 to
the measurement times to make the data unequally spaced and more realistic. The individual-specific,
shared, and two of the categorical covariates’ age effects are set to be relevant with lengthscale 24 months
for shared and 12 months for other age effect components. Also two of the additional continuous
covariates as set as relevant with lengthscale 1. Two of the continuous and two of the categorical
covariates are left as irrelevant. Furthermore, half of the individuals are considered diseased and a
disease effect time is drawn for each of them separately, uniformly from the interval [36, 48] months.
This time point is used to simulate a nonstationary disease effect, using the kernel in Eq. 9, with the
steepness a drawn randomly from N (0.5, 0.12). However, during inference, we fix the effect time to the
next actual measurement time. We first generate 100 data sets where also a disease-related age effect
is relevant, with lengthscale 1, and then another 100 data sets with no disease effect. Gaussian noise is
added so that signal-to-noise ratio is 3.
LonGP uses a greedy forward search where at each step, the component that has the best leave-
one-out cross-validation or stratified cross-validation score is added to the model if the score exceeds a
pre-specified threshold. We use the default thresholds LOOCVR = 0.8 and SCVR = 0.95. By default,
the id covariate has to be in the model for LonGP and the continuous covariates are searched first before
the categorical ones. When categorical covariates are added, also their interaction component with age
is added if age is already in the model. If the shared age component is not in the model, the categorical
covariates act only as group offsets. In order to create a comparable scenario with this complicated
procedure, we use LonGP so that also the shared age component is by default in the model, and leave
the id and age covariates out of the selection problem, while their effect is still modeled. The covariates
that are supposed to be classified as either relevant or irrelevant are therefore categorical covariates zi,
i = 1, . . . , 4, continuous covariates xi, i = 1, . . . , 4 and the disease-related age. The hyperparameter
priors are same for both models. However, the input warping steepness cannot be inferred in LonGP,
so we use its default fixed value a = 0.5. We use a categorical kernel (returns 1 if categories are same,
0 otherwise) for terms that contain a categorical covariate, because LonGP can not model zero-sum
deviations.
Since LonGP uses a sequential model search, we cannot compute full ROC curves for it. Therefore
we compare performances by counting how often each covariate is selected. Figure S3b shows the number
of times each method selected different covariates across the 100 simulated data sets for both the case
where the disease effect was and was not relevant. LonGP tends to select very few covariates, and to
have comparable results for lgpr, we set a rather low threshold of T = 80 in Eq. 23. We see that lgpr
can more clearly distinguish the relevant covariates from the irrelevant covariates. In this simulation
scenario, the total covariate selection accuracy for lgpr is 81.4% when the disease-related age is relevant
and 87.0% when it is not. Corresponding numbers for lonGP are 65.0% and 75.2%. Furthermore, the
average run time per data set is approximately five times longer for LonGP (Figure S3b).
3.3 Heterogeneous modeling of the disease effect
To test the heterogeneous disease effect modeling approach, we generate data with 16 individuals out
of which 8 are diagnosed with the disease but so that the disease effect is generated for only Naffected =
0, 2, 4, 6 or 8 of them. The measurement points in this experiment are exactly 12, 24, 36, 48, 60 and
72 months, and the disease effect time for each diagnosed individual is sampled uniformly from the
interval [46, 48] months, but it is observed at 48 months. In addition to the disease component, we
also create relevant individual-specific and shared age effects, and one relevant (z1) and two irrelevant
(z2, z3) categorical covariates that interact with age. The used lengthscales are 24 months for shared
age, 1 for the disease component and 18 months for other components. All covariates are considered
to be subject to selection. We set the signal-to-noise ratio to 3 and simulate a total of 500 data sets,
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100 for each case Naffected = 0, 2, 4, 6, 8. In the case Naffected = 8 all diseased individuals have the
effect and for Naffected = 0 none do, meaning that the disease-related age is an irrelevant covariate. For
each data set replication, the inference is done using both a heterogeneous and homogeneous model.
The results in Figure S7 show that heterogeneous modeling improves covariate selection accuracy, and
the improvement is clearest when only 2 of the individuals actually have the effect. In heterogeneous
modeling, the samples of the individual-specific disease effect magnitude parameters βid indicate the
affected individuals. See Figure S8 for a demonstration of heterogeneous model inference.
3.4 Modeling the uncertainty in disease effect time
To test the model where the disease effect time is considered to be uncertain, we simulated data where the
observed disease initiation time is later than the true generated effect of the disease-related age covariate.
In this experiment we have 12 individuals, 6 of them diseased, measured at 12, 24, 36, 48, 60, 72, 84 and 96
months and we use a signal-to-noise ratio 1. The components and covariates, as well as the lengthscales
are same as in the previous experiment. For each diseased individual q, the real effect age t′q is sampled
from the normal distribution with mean 36 and standard deviation 4 months Figure S5a. The disease
is considered observable at age τq = min{t′q + t∗q , 96} months, where t∗q is drawn from the exponential
distribution with rate parameter 0.05 ( Figure S5b). The disease onset is then observed to be at the
next measurement time point
tobsq = arg min
t
t s.t. t ≥ τq, t ∈ {12, 24, 36, 48, 60, 72, 84, 96} (25)
and the observed disease ages are computed as xdisAge = xage − tobsq . We simulate 300 data sets so that
the relevant covariates are
• id, age and z1 in the first 100
• age, diseaseAge and z1 in the next 100
• id, age, diseaseAge and z1 in the last 100
data sets. For each data set we run the inference first by fixing the effect time to equal the clinically
determined onset time, and then using two different priors for the effect time uncertainty. The first prior
is ∆t ∼ Exp(0.05), meaning that the observed onset is most likely, and prior mass decays exponentially
towards birth. An oracle prior, which is exactly the distribution that is used to sample the real effect
time, is used for reference. The results in Figure S5c show that the uncertainty modeling improves the
covariate selection accuracy, and the oracle prior performs best as expected. Especially, we see that
detection of the disease-related age covariate is more accurate when the uncertainty is being modeled
Figure S5d. See Figure S6a for a demonstration of effect time inference.
3.5 Non-Gaussian data
To demonstrate the benefit of using a proper observation model, we generate negative binomially dis-
tributed count data and model it using different observation models. We generate measurements for 10
individuals at timepoints 6, 12, 18, 24, 30, 36, 42 and 48 months with jitter σt = 0.2 months. The data
contains the covariates id and age and additionally two categorical covariates z1, z2 and two continuous
covariates x1, x2. We use lengthscale 12 months to simulate the shared age component and 6 months for
the group and individual specific age effects. We simulate 300 data sets so that the relevant covariates
are
• age , x1 and z1 in the first 100
• id, age, x1, and z1 in the next 100
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• just x1 and x2 in the last 100
data sets. The process f is generated from the additive Gaussian process prior and scaled to have
variance 2. The measurements are drawn from y ∼ NB (exp(−1 + f), φ) with φ = 2. This will create
integer-valued data with many zeros. For each data set, we run the inference using a Gaussian and
negative binomial observation model, with 4 MCMC chains and 4000 iterations each chain. The latter
involves the sampled parameter φ, for which we use a Log-Normal(1, 1) prior. Results in Main Figure 2d
confirm that the covariate selection for this kind of negative binomial distributed count data cannot be
done reliably using the Gaussian observation model, whereas using the correct observation model in lgpr
model improves the covariate selection accuracy. For reference, we also run the inference using Gaussian
observation model but so that the data is first transformed through the mapping y 7→ log(1 + y). We
note, however, that covariate selection performance of the Gaussian model improves (relative to that
of negative binomial model) when data has higher count values and dispersion is smaller, i.e., when
negative binomial model is approximated well by the Gaussian model.
4 Longitudinal proteomics data analysis
Protein intensities were measured from plasma samples of 21 children, with nine measurement time
points for each child, resulting in a total of 189 data points for most proteins. We chose to analyze
1538 proteins which were chosen by requiring that at least 50% of the measurements must have non-
missing values. The exact sample sizes after discarding missing data for each protein are shown in
Table S1. 11 of the children developed Type 1 diabetes (T1D), and for those individuals we defined the
disease effect time to be the seroconversion age, which was defined as age at the first detection of one
or multiple T1D autoantibodies [14]. Like in [4], we performed our modeling using five covariates: id,
age, diseaseAge, sex and group (case/control). Each protein was analyzed separately, and we followed
the preprocessing described in [14] to get normalized protein intensities. Of the categorical covariates,
id and sex are modeled as age-dependent category-specific deviations from the shared age effect, and
group is a constant group offset variable. For diseaseAge, the variance mask kernel in Eq. 9 is used.
We used the Gaussian observation model after normalizing the protein intensities. We performed the
analysis for all proteins using both the the homogeneous and the heterogeneous disease effect modeling
approach (Eq. 11), in which case the prior for the additional β parameters is Beta(0.2, 0.2). We run
four independent MCMC chains, using 4000 iterations for each protein, discarding the first half of each
chain as warmup. For a handful of proteins the mixing of chains was slower (Rˆ-statistic [15] > 1.05
with initial number of iterations), and we rerun the sampling doubling the number of iterations. We
used the 95% threshold (in Eq. 23) for covariate selection. In order to avoid fitting to artifacts in the
data, we interpreted the heterogeneous modeling results so that the disease-related age covariate was
selected only if it was found for at least three case individuals (median of the individual-specific disease
effect magnitude parameter > 0.5).
5 Related research
Frequentist modeling of longitudinal data has a long history [16, 17]. Random-effect models, marginal
models, and conditional models are the three main types of extensions of generalized linear models for
longitudinal data, and they make differing assumptions about the joint distribution of the measured
responses. Random-effect models [18] assume that a subset of the regression coefficients vary across
subjects according to a certain distribution, usually normal. Marginal models can be used to make
inferences about population averages, since they model the average response of a sub-population that
has the same value for a certain covariate. Parameters of marginal models can be estimated using the
generalized estimating equations [19], which do not assume any specific form of the joint distribution of
a subject’s measurements, but are based on a quasi-likelihood approach. Conditional models are usually
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transition models, where conditional distribution of each response is a function of preceding responses
and covariate values [16]. There exist also semiparametric and nonparametric approaches, such as local
polynomial and spline methods [20]. Generalized linear mixed models [21], which contain both fixed and
random effects have remained a highly used approach. This is because they are an interpretable, fast
and powerful model family that usually can be fitted using off-the-shelf software for different types of
response variables. The popular R-package lme4 [12] can be used to fit mixed models using the maximum
likelihood or restricted maximum likelihood (REML) method. In practice, however, is is difficult to
fit mixed models which involve effects of many crossing categorical covariates, and lme4 will report a
singular fit or imperfect convergence. Hierarchical Bayesian models [22] provide an alternative where
the population and group-level parameters have a clearer interpretation, uncertainty can be assessed
and posterior diagnostics studied. Their software implementations include brms [23, 24] and rstanarm
[25]. Gaussian process ANOVA [3] is another approach to separate shared effects and interactions of
various categorical factors. The mgcv package implements generalized additive mixed models [26] based
on penalized regression splines.
Longitudinal studies commonly collect many covariates and typically only part of them have an effect
on the response. Determining the relevant covariates is a critical research question which can provide
important insights about the modeled phenomenon. The covariate relevance information can be used
to obtain a better interpretability of the disease development, build models for better predictions and
reduce future measurement costs. Despite its importance, the covariate selection aspect for longitudinal
data has been largely overlooked. In general, the covariate selection problem is often approached by
defining a set of alternative models, and recasting it as a model selection problem. Alternatively,
significance of different model terms can be tested in a frequentist manner, but for mixed models
it is not straightforward to determine the denominator degrees of freedom when computing p-values
[27]. Approaches for model selection for linear mixed models, reviewed in [28], include for example
information criteria and shrinkage methods. Bayesian models can be compared by information criteria
or cross-validation [10], but in general one would need to perform exhaustive search over different models
to select the relevant covariates.
GP is a popular Bayesian nonparametric model that is commonly used for time series modeling
[1, 29]. GPs can be made additive by defining an additive kernel function, which provides a flexible
yet interpretable model class. Additive GP models can be interpreted analogously with the standard
linear mixed models, with the exception that each component in an additive GP model is a flexible
nonparametric function. The balance between interpretability and flexibility in time series modeling
was initially studied by Plate [30], who proposed to use a sum of univariate and multivariate kernels.
An additive kernel that contains all interaction terms was proposed by Duvenaud et al. [2] and more
complex decomposable additive structures were proposed in [31]. While much of the work on learning GP
regression models from data has relied on type-II maximum likelihood estimation, Bayesian techniques
have also been proposed in [32, 30, 33]. More recently, semi-parametric models that mix linear, spline
and GP components [34] as well as more general additive GPs [35, 36, 37] have been proposed. Additive
GP models that are particularly designed for longitudinal study designs include a method of Quintana
et al. [37] and LonGP [4]. LonGP uses a stepwise search algorithm for uncovering relevant covariates
and was shown to provide accurate covariate selection. However, stepwise search strategies are prone to
overfitting at different stages of the search procedure, and the cross-validation based model selection of
LonGP requires the user to set two different non-trivial threshold values that guide the model search.
The stepwise algorithm requires sampling the posterior of GP hyperparameters at each stage, which
becomes computationally exhaustive in the presence of many covariates. Furthermore, search algorithms
in general will only provide the researcher the information about which model was selected, instead of
a relevance measure for all covariates.
Our way of defining the proportion of variance explained by signal is closely related to the recently
introduced Bayesian R2-statistic [8]. Like our method, it takes into account the problem that the
classical definition of R2 is not suitable for Bayesian models, since the variance of the predicted values
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can be larger than the variance of the data. One question that can arise is why not directly use
the samples of the kernel hyperparameter α2j to divide the proportion of signal between the model
components. While they indeed are informative of the effect sizes, we find that studying the posterior
of the function components more clearly distinguishes the relevant components. Also the component
lengthscales have been used to determine covariate relevance, in an approach that is usually termed
automatic relevance determination (ARD) [38]. The motivation is that smaller lengthscales would
indicate more relevant components, but ARD has shown to rather measure nonlinearity than relevance
[39]. Recently, decomposing the variance explained by different predictors of general machine learning
models has also been approached by computing Shapley values, which have game theoretic basis [40].
Shapley values for each predictor are obtained as a solution to a coalition game, in which predictors
have different contributions to the coalition, i.e. the total prediction.
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A Proof of the zero-sum property
Theorem 1.
Let r ∈ {1, . . . ,M} =M, where M ≥ 2. We define a kernel function
kzerosum(r, r
′ |M) =
{
1 if r = r′
− 1M−1 otherwise
. (26)
Let kbase : (X ,X ) → R be another kernel function. Furthermore, we denote their product kernel by
k = kzerosumkbase. Now assume that function f : (X ,M) → R has GP prior f ∼ GP(0, k). Then for
any t ∈ X , the prior distiribution of the sum g(t) = ∑Mr=1 f(t, r) is the Dirac delta distribution at zero.
Proof.
We study the product kernel in the limit k = lim→0+ k, where
k(x,x
′) = k(x,x′) +  · 1(x,x′), (27)
and 1(x,x′) is one if the inputs are the same data point, and 0 otherwise. Assume that f has GP prior
f ∼ GP(0, k) and  > 0. For any fixed t ∈ R, we have ft ∼ N (0,K), where
ft =
 f(t, 1)...
f(t,M)
 and K =

kbase(t, t) +  −kbase(t,t)M−1
. . .
−kbase(t,t)M−1 kbase(t, t) + 
 . (28)
Since g(t) =
∑M
r=1 f(t, r) = 1
>ft, we get
g(t) ∼ N (µ, σ2 ) , (29)
where µ = 1>0 = 0 and σ2 = 1>K1 = M · . Therefore, the limit distribution of g(t) is
lim
→0+
N (0, σ2 ) = lim
→0+
N (0,M · ) = δ0, (30)
i.e. the Dirac delta distribution.
Corollary.
With any data, also the posterior distribution of g(t) is δ0.
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 age
0→48
Figure S1. Illustration of the zero-sum kernel for modeling category-specific time-dependent
deviations from a shared age profile. Each row shows a kernel matrix and four randomly drawn function
realizations for 8 individuals on age span 0 to 48 months. Marginal standard deviation α = 1 has been used
for all kernels. a) A standard squared exponential kernel for modeling shared age effects, with lengthscale 24
months. b) The new zero-sum kernel with two categories (Female, Male) and lengthscale 12 months. c) A
zero-sum kernel with three categories (Country 1, Country 2, Country 3) and lengthscale 12 months. d) A
zero-sum kernel with 8 categories (id = 1, . . . , 8) and lengthscale 12 months, for modeling individual-specific
time-dependent deviations from the shared age profile.
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t+
a b c
Figure S2. Visualization of the prior distributions used for model parameters. Top row shows
probability density functions of the distributions and bottom row shows the corresponding densities on log-scale.
a) Prior distributions for kernel function parameters. A half Student-t prior is used for the marginal standard
deviation parameters α, because it has a long tail but its mode is at zero. A log-normal prior is suitable for the
lengthscales ` because it does not allow values near zero. An inverse gamma distribution is used for the input
warping steepness parameter a. b) Prior distributions for likelihood function parameters. An inverse gamma
distribution is used for the noise variance parameter σ2n when using a Gaussian likelihood model. A log-normal
prior is used for the inverse overdispersion parameter φ of the negative binomial distribution. c) A beta prior
for the individual-specific disease effect magnitude parameters is used to prefer parameter values close to either
zero or one. Here the beta distribution density is plotted at points 0.01 ≤ x ≤ 0.99.
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Figure S3. Covariate selection accuracy of lgpr is superior to previous methods. a) Comparison with
linear mixed effect modeling and demonstration of our method’s scalability. The panels show ROC curves for
the problem of classifying covariates as relevant or irrelevant, when the total number of data points is N = 100,
300 and 600, respectively. b) Comparison against LonGP in the task of selecting relevant covariates. The bar
plots show the fraction of times each covariate was chosen in the final model over 100 simulated data sets. Red
text indicates the covariates that were relevant in generating the data. The left panel shows results for 100
simulations that includes the disease-related age (diseaseAge) as a relevant covariate. The center panel shows
results for 100 simulations where the disease-related age was not a relevant covariate. The right panel shows
distribution of runtimes over the total 200 simulations for both methods. The bar lengths are average runtimes,
and the turnstiles indicate runtime standard deviations.
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age
Figure S4. Illustration of different kernels for modeling a non-stationary disease effect. Each row
shows a kernel matrix and four randomly drawn function realizations for 8 individuals (4 case, 4 control) on
age span 0 to 48 months. Marginal standard deviation αdiseaseAge = 1, lengthscale `diseaseAge = 1 and warping
steepness a = 0.5 have been used for all kernels and the disease effect time is at 24 months. a) Standard non-
stationary kernel using the input warping approach. The input warping allows the function to vary in time only
near the disease effect time for cases, but also allows a baseline difference between cases and controls. b) The
new variance masked kernel, which does not allow any difference between groups until close to the effect time
and after it. c) Heterogeneous version of the variance masked kernel, which in addition allows the magnitude
of the disease effect to differ between case individuals. Individual-specific disease effect magnitude parameters
have been set to β1 = 1, β2 = 0.5, β3 = 0.3, β4 = 0.1. d) The input warping and variance masking functions.
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Disease effect time
Fixed (auc = 0.918)
Uncertain, prior 1 (auc = 0.957)
Uncertain, prior 2 (auc = 0.964)
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Disease effect time
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Figure S5. Modeling the uncertainty in the disease effect time enhances covariate selection
accuracy. Results of an experiment where data is simulated so that the disease effect can occur earlier than the
observed disease initiation. (a) The distribution from which the real effect time for each diseased individual is
sampled from. (b) The distribution from which the disease detection delay is sampled from. (c) ROC curves for
covariate selection with and without modeling the effect time uncertainty. The yellow curve is for a model where
the prior of effect time was the same as the distribution in (a) (prior 1). The red curve is for a model with an
exponential decay prior for the difference between the effect time and observed onset (prior 2). The blue curve
is for a model with effect time fixed to equal the observed initiation time. (d) ROC curves for the same three
models, in the task of classifying just the disease component as relevant or irrelevant.
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Figure S6. Demonstration of inferring the uncertain disease effect time using simulated data. a)
The data-generating process, noisy data and fits of the uncertain and fixed models plotted for each of the 12
individuals. The fixed model uses the observed disease initiation time (dashed blue line), whereas the uncertain
model infers it from data. The uncertain model can more clearly identify the disease effect, because disease
initiation is observed later than the true effect occurrence (yellow line). Model fits are the posterior predictive
means, computed using posterior mean parameters. b) Posterior distributions of each inferred function compo-
nent for both models, using posterior mean parameter values. For clarity, standard deviations are not shown for
f (1) and f(total) =
∑6
j=1 f
(j). c) Component relevances inferred by both models for this data realization. The
true relevant components were f (2), f (3) and f (4). The simulated data was generated as explained in Section 3.4,
except with signal-to-noise ratio 3.
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Figure S7. Heterogeneous modeling of the disease effect is beneficial when only some of the
diagnosed individuals are affected by the disease. a) The ROC curves for covariate selection using
a heterogeneous and a homogeneous disease model in the simulated data experiments with 0, 2, 4, 6 and
8 out of the 8 diagnosed individuals affected, respectively. b) Inferring the individual-specific disease effect
magnitude parameters can reveal the individuals affected by the disease. The boxplots show the distributions
of the posterior medians of βid, id = 1, . . . , 8 of the heterogeneous model, over 100 simulated data sets. The
box is the interquantile range (IQR) between the 25th and 75th percentiles, vertical line inside the box is the
50th percentile, and the whiskers extend a distance of at most 1.5 · IQR from the box boundary. Each panel
corresponds to the same experiment as the one above it.
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Figure S8. Demonstration of inferring a heterogeneous disease effect using simulated data. Indi-
viduals 01-08 are cases, but the disease effect is generated only for individuals 01-04. a) Kernel density estimates
for the posteriors of the individual-specific disease effect magnitude parameters βid, id = 1, . . . , 8. b) The data-
generating process, noisy data and fits of the heterogeneous and homogeneous models plotted for each of the
16 individuals separately. Model fits are the posterior predictive means, computed using maximum a posterior
(MAP) parameters. c) Posterior distributions of each inferred function component for both models, using MAP
parameter values. For clarity, standard deviations are not shown for f (1), f (3) and fsum =
∑6
j=1 f
(j). The true
relevant components were f (2), f (3) and f (4). The simulated data was generated as explained in Section 3.3,
except with signal-to-noise ratio 5.
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